Emerging Markets Earnings Roundup: Novartis (Part 5)
This article was originally published in PharmAsia News
Executive Summary
Novartis spent considerable effort on the first quarter earnings call explaining the details of its deal with GlaxoSmithKline, but found time to discuss emerging markets as well with China in the lead once again.